Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive ibuprofen for pain control after mandibular impacted third molar extraction
ChiCTR2200057962Phase 4Not yet recruiting
- Sponsor
- Beijing Stomatological Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen in postoperative pain and Impacted lower third molar (2 arms), sponsored by Beijing Stomatological Hospital. Primary endpoint: VAS score at 24 hours after surgery. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
ibuprofen
03
Conditions
postoperative painImpacted lower third molar
Beyond the preview
Go deeper on ChiCTR2200057962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057962.